Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D)

NCT01303224 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

565

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome With Diarrhea

Interventions

DRUG: Ibodutant
DRUG: Ibodutant
DRUG: Ibodutant
DRUG: Placebo

Sponsor

Menarini Group